Serina Therapeutics Inc. (SER)
NYSE · Healthcare
Serina Therapeutics Inc. Operating Income 2017–2025
Serina Therapeutics Inc. annual/quarterly operating income history and growth rate from 2017 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Serina Therapeutics Inc. operating income for the quarter ending September 30, 2025 was -6.4 M, a 20.33% increase year-over-year.
- Serina Therapeutics Inc. operating income for the twelve months ending September 30, 2025 was -23.1 M, a 169.08% increase year-over-year.
- Serina Therapeutics Inc. annual operating income for 2025 was -24.0 M, a 40.91% increase from 2024.
- Serina Therapeutics Inc. annual operating income for 2024 was -17.0 M, a 444.84% increase from 2023.
- Serina Therapeutics Inc. annual operating income for 2023 was -3.1 M, a 55.14% decrease from 2022.
- Serina Therapeutics Inc. annual operating income for 2022 was -7.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Serina Therapeutics Inc. Operating Income — FAQ
Serina Therapeutics Inc. (SER) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Serina Therapeutics Inc.'s operating income?
Serina Therapeutics Inc. (SER) reported operating income of -$24M for fiscal 2025.
Where can I see SER's operating income history?
The chart and table above show Serina Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.